Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05321368 · ClinicalTrials.gov registry record · NA

A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities

A NA study of Hypertension and Diabetes, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
425
Enrollment target
3
Study locations

NCT05321368: Recruiting NA study of Hypertension and Diabetes, sponsored by Johns Hopkins University.

NCT05321368 is a NA study of Hypertension and Diabetes that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 425 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (88% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05321368, a NA study of Hypertension and Diabetes, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
425 participants
Enrollment target
3
Study locations

Study Summary

The LINKED- HEARTS Program is a multi-level project that intervenes at the practice level by linking home blood pressure monitoring (HBPM) with a telemonitoring platform (Sphygmo). The program incorporates team-based care by including community health workers (CHWs) and pharmacists to improve the outcomes of multiple chronic conditions (reduced blood pressure (BP), lower blood sugar, and improved kidney function). The LINKED-HEARTS Program will recruit a total of 600 adults with uncontrolled hypertension (BP ≥ 140/90 mm Hg) AND either type 2 diabetes or chronic kidney disease (CKD) across 16 community health centers or primary care practices serving high-risk adults. This cluster-randomized trial consists of two arms: (1) enhanced "usual care arm," wherein patients will be provided with Omron 10 series home BP monitors and will be managed by the patients' primary care clinicians as usual; and (2) the "intervention arm" which will integrate HBPM telemonitoring, a CHW intervention and provider-level interventions into the usual clinical care to improve BP control and provide support for self-management of chronic conditions. The study pharmacist will conduct telehealth, use the Sphygmo app and the Pharmacist Patient Care Process to collaborate with other providers to optimize pharmacologic therapy to improve hypertension outcomes and with payors to ensure consistent access to drug therapy.

Primary Outcome

Percent of patients with controlled Blood Pressure (\<140/90 mm Hg).

Interventions

  • BEHAVIORAL LINKED-HEARTS Program

Study Locations (3)

Maryland

  • Johns Hopkins Community Physicians - Baltimore
  • Choptank Community Health Systems - Denton

District of Columbia

  • Unity Health Care - Washington D.C.

Trial Details

FieldValue
Enrollment Target 425 participants
Start Date 2023-10-16
Est. Completion 2027-04-22
Phase NA
Johns Hopkins University

1,448 total trials

What NCT05321368 shows while recruiting

NCT05321368 is an interventional study that assigns participants to a tested intervention. The registered 425 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (88% lower).

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which LINKED-HEARTS Program is the first listed.

NCT05321368 reports a single indexed study location in Maryland, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05321368 about?

NCT05321368 is a clinical study titled "A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities". The LINKED- HEARTS Program is a multi-level project that intervenes at the practice level by linking home blood pressure monitoring (HBPM) with a telemonitoring platform (Sphygmo). The program incorporates team-based care by including community health workers (CHWs) and pharmacists to improve the ou...

What is the current status of trial NCT05321368?

This trial is currently recruiting. It is a NA study. The enrollment target is 425 participants. The study started on 2023-10-16. Estimated completion is 2027-04-22.

What conditions does trial NCT05321368 study?

This clinical trial studies the following conditions: Hypertension, Diabetes, Chronic Kidney Diseases, High Blood Pressure.

What interventions are being tested in trial NCT05321368?

The interventions under investigation include: LINKED-HEARTS Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05321368?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05321368 being conducted?

This trial has 3 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05321368's enrollment target sits among peer trials

425 141st of 470 higher than 329 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04265430 · 425 participants · Phase 4

    Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

  • NCT04278690 · 425 participants · NA

    Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

  • NCT05340738 · 425 participants · NA

    AI-Based Fidelity Feedback to Enhance CBT

  • NCT06693687 · 425 participants · NA

    A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05321368, the US trial registry maintained by the National Library of Medicine. NCT05321368 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.